SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Salix Pharmaceuticals Ltd and Certain Officers -- SLXP

NEW YORK, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Salix Pharmaceuticals Ltd ("Salix" or the "Company") (Nasdaq: SLXP ) and certain of its officers. The class action, filed in United States District Court, Eastern District of North Carolina, Western Division, and docketed under 14-cv-00804, is on behalf of a class consisting of all persons or entities who purchased Salix securities between August 7, 2014 and November 6, 2014, inclusive (the "Class Period"). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").

If you are a shareholder who purchased Salix securities during the Class Period, you have until January 6, 2015 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, x237. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.

Salix Pharmaceuticals, Ltd., a Delaware corporation, acquires, develops, and commercializes prescription drugs and medical devices to treat various gastrointestinal diseases in the United States. Salix Pharmaceuticals, Ltd. was founded in 1989, is headquartered in Raleigh, North Carolina, and its shares trade on the NASDAQ under the ticker symbol "SLXP".

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company overstated demand for Salix's drugs; (2) the Company understated wholesaler inventory levels for Salix's products; (3) Salix's internal controls over financial reporting was ineffective; and (4) as a result of the foregoing, Salix's public statements were materially false and misleading at all relevant times.

On November 6, 2014, after the close of trading, the Company issued a press release announcing the resignation of its Chief Financial Officer, Adam C. Derbyshire. Minutes after issuing the press release, the Company issued an earnings release and filed a Form 8-K announcing its financial and operating results for the third quarter ending September 30, 2014 and hosted an earnings conference call with investors and analysts.

The Company also disappointed investors by reporting earnings and revenues for the third quarter and providing guidance for fourth quarter earnings and revenues, below the projection of analysts. According to the release, the Company had revenue of $355 million in the third quarter, up 49% from the same period last year, and reported earnings per share of $1.53. This was below the consensus among Wall Street analysts, which had expected revenue of $392 million and earnings per share of $1.55. In the earnings release, the Company also provided guidance for the fourth quarter, forecasting that earnings per share will be $1.16, on revenue of $325 million, compared with the average projection of analysts of $1.95 per share on revenue of $436 million.

As a result of this news, shares of Salix fell $47.08 per share, or 33.98%, to close at $91.47 per share on heavy trading volume, on November 7, 2014.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com .

Robert S. Willoughby Pomerantz LLP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yoodli's No. 9 Ranking Signals Enterprise AI Traction

Updated Category News Views 35

Ninth place can be easy to dismiss until you notice the company is sitting near the top of a 500-name growth list. Yoodli's No. 9 position on Deloitte's 2026 Technology Fast 500 is a meaningful signal that its AI-based coaching and workforce-skills pitch is getting traction inside large organizations. It is not a revenue disclosure, it is not a valuation marker, and...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 96

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading
Epsium's Inventory Pile Looms Over Weak First Half

Updated Category News Views 73

A warehouse full of bottles is not a balance-sheet fortress when buyers are backing away. Epsium Enterprise’s first-half 2026 report is a rough read: revenue collapsed 51.8% to $1.47 million, gross profit fell to $175,353, and cash slid to $612,761 at June 30. This is not a subtle slowdown. Macau’s premium Chinese-liquor market has been weak on both demand and...

Continue Reading
Three Cash Buyouts Draw Fresh Shareholder Scrutiny

Updated Category News Views 149

Three cash-price tags landed on the tape with a lawyerly asterisk attached: are public holders actually getting a fair shake? On November 18, 2026, Halper Sadeh LLC said it was investigating proposed sales involving Surgery Partners, Braze and CCC Intelligent Solutions. That is not a finding of misconduct, and investors ought to keep that distinction bolted firmly to the...

Continue Reading
GE Aerospace Backs Service Members With $100K Gift

Updated Category News Views 45

A six-figure commitment can look tiny beside jet-engine budgets, yet it can matter a great deal when it reaches people navigating the awkward jump from military service into civilian life. GE Aerospace has committed $100,000 to Embry-Riddle Aeronautical University to support transitioning service members. That is the whole heart of this announcement, and frankly, it is...

Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 88

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading
Insider Risk Makes Human Judgment a Security Priority

Updated Category News Views 156

A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...

Continue Reading
Tim Hortons Bets on ELF Cheer for U.S. Holiday Visits

Updated Category News Views 23

Nothing says holiday restaurant marketing quite like putting spaghetti-shaped whipped topping on hot chocolate and trusting a 2003 movie to do the selling. Tim Hortons is rolling out an ELF-inspired menu at participating U.S. locations starting November 18, 2026, pairing the chain with Warner Bros. Consumer Products and mining Buddy the Elf's sugar-fueled world for a...

Continue Reading
Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 221

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 293

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading

Top 5 Most Recently Viewed Articles

Bouygues Announces Updated Share and Voting Rights Information

Updated Category News Views 382

Monthly Disclosure of Shares and Voting Rights by Bouygues The importance of transparency in corporate governance cannot be overstated, and Bouygues, a prominent player in the construction and telecommunications sectors, prioritizes this. Presenting clear, timely, and precise updates regarding shares and voting rights reflects the company’s commitment to its...

Continue Reading
Capital Raises KT&G Stake to 8.2% Amid Global Gains

Updated Category News Views 37

Capital Research Strengthens Hold in KT&G Things have been heating up in Seoul. Capital Research and Management Company, a heavyweight in fund management, has just pushed its stake in KT&G up to 8.22%. That's a leap from the earlier 5.61% in May, and 7.21% by June. These guys manage a whopping $3.3 trillion in assets—so when they make a move, others tend to perk up and...

Continue Reading
Butterfly Network and Rutgers Study Show Impact of POCUS

Updated Category News Views 182

Revolutionizing Hospital Care with POCUS Technology BURLINGTON, Mass. & NEW YORK-- Butterfly Network, Inc. (NYSE: BFLY), a pioneering digital health company, has launched a significant study in collaboration with Rutgers Robert Wood Johnson Medical School. This research emphasizes the transformative influence of point-of-care ultrasound (POCUS) technology on patient...

Continue Reading
Staying Ahead of the Curve: Why Trading Compliance Is Now a Strategic Advantage

Updated Category Investing Views 1309

In today’s fast-evolving financial landscape, trading compliance has become more than just a regulatory requirement—it’s a defining pillar of strategic success. As regulators tighten their grip and technology uncovers previously invisible risks, firms that embrace advanced compliance measures are not only staying protected but also gaining a competitive edge....

Continue Reading
Key Insights Into the Expanding Hydrogen Storage Sector

Updated Category News Views 180

The Rise of the Hydrogen Energy Storage Market The global hydrogen energy storage market is on the verge of significant growth, with projections indicating a remarkable CAGR of 72.1%, potentially reaching a substantial $23.7 billion by the end of 2029. This surge reflects a shift toward cleaner energy solutions, driven by advancements in technology, policy support, and a...

Continue Reading